glp-1 without diabetes medications linked to major drop in pancreatic, colorectal cancer risk https://www.medicalnewstoday.com/articles/weight-loss-drugs-glp-1 -slash-risk-4-types-cancer-50-or-more-study GLP-1 Receptor Agonists and Research

Oral GLP-1 RAs are also under development, and early data show similar weight loss efficacy to semaglutide 2.4 mg [84], which could improve convenience and potentially reduce costs through improved manufacturing and distribution efficiency

With the right guidance and treatment plan, retatrutide can be an effective medication for the treatment of obesity.

however, not all do

Last reviewed: July 12, 2026 Last updated: July 12, 2026 Written by: Jay Hastings, CEO of PlexusDx Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations

The network analysis was performed using R (version 4.1.2, updated by 21 November 2021) netmeta package

doi: 10.1056/NEJMoa2032183 101 RubinoDMGreenwayFLKhalidUONeilPMRosenstockJSrrigRet al